International Society for NeuroVirology & Society on NeuroImmune Pharmacology
April 10-14, 2018 | Chicago, Illinois, USA
The Joint Meeting of the International Society for NeuroVirology (ISNV) and the Society on NeuroImmune Pharmacology (SNIP) brought together leading researchers, clinicians, and professionals to share cutting-edge research at the intersection of neuroscience, virology, and immunology.
This collaborative event featured presentations on novel discoveries in neuroimmune interactions, viral pathogenesis in the nervous system, and innovative pharmacological approaches to treating neuroimmune disorders.
Date: April 10-14, 2018
Location: Chicago, Illinois, USA
Focus Areas:
Abstracts Presented
Countries Represented
Scientific Sessions
Days of Science
Studies exploring how viruses infect and affect the central nervous system, including HIV, Zika, and other neurotropic viruses.
Research on drugs and compounds that modulate neuroimmune interactions for therapeutic benefit.
Investigations into how immune responses in the nervous system contribute to neurological diseases.
Translational research focused on developing new treatments for neuroimmune and neurovirological disorders.
Studies elucidating the molecular interactions between neural and immune cells.
Development and application of innovative models to study neuroimmune interactions.
This study investigated the role of microglial activation and cytokine production in the pathogenesis of HIV-associated neurocognitive disorders (HAND). The research demonstrated that specific inflammatory pathways contribute to neuronal damage in patients with HAND 1 .
The presentation highlighted new compounds that target specific immune cell populations in the CNS to reduce neuroinflammation in experimental models of multiple sclerosis. These approaches showed promise for reducing disease progression while minimizing systemic side effects 2 .
This research explored how Zika virus infection during pregnancy affects fetal brain development, with a focus on the contribution of maternal and fetal immune responses to the observed neurodevelopmental abnormalities 3 .
The study examined mechanisms of blood-brain barrier disruption in various neuroinflammatory conditions and evaluated potential therapeutic strategies to restore barrier integrity and limit CNS inflammation 4 .